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A HISTORY AND BACKGROUND ON DIETARY SUPPLEMENTS

As the pace of life speeds up, a greater number of adults are looking for that
“quick fix” when it comes to their health and wellbeing. Fifty years ago, resorting
to a pill or shake for breakfast would have been questionable; yet nowadays,
sitting down for a hearty, nutrient dense meal is a rarity. Adults across the country
are turning to meal replacements and dietary substitutes to fuel their lifestyles.
Population ageing, retiring baby boomers and a rising awareness of diet-health
related disease (e.g. obesity, diabetes) are the major driving forces behind the
expansion of preventative consumption of dietary supplements as a proactive way
of maintaining good health.1 Furthermore, there is a willingness to “try anything”
in the search of managing ones chronic disease (patients with chronic diseases
often take more supplements than the general population). 2 People as a whole
have greater general awareness of diet-health issues and trends toward proactive
health behaviours have increased consumers’ demand for more products with
identifiable health benefits. 3 Whether ordered online or purchased at the drug
store, adults have easy access to dietary supplements without a prescription, and
most consume them without their health care provider’s advice or knowledge. 4
In 2016 the diet supplement business was responsible for employing more than
750,000 people. The industry alone was worth $122 billion, and within the past
two years “[that] number has continued to grow and prosper.”5 The effects on the
U.S. economy are positive, but unfortunately, the public are at risk of suffering
from the potential detrimental consequences that some of those supplements could
have on one’s health. While there is an extensive use of dietary supplements, there
is little quality standardization of these products, and it is difficult for health care
professionals and consumers alike to discern their safety and quality.6 Although
supplements cannot be marketed for the treatment or prevention of disease, they
are often taken to address symptoms or illnesses, as well as to maintain or improve
overall health.7 Even with this stipulation in place, “[a] 2003 review of claims
made on 273 websites selling dietary supplements found that 55% of sites made
unauthorized and illegal claims to treat, prevent, diagnose, or cure specific
1

Gavura Scott, Who Takes Dietary Supplements, SCIENCE-BASED MEDICINE (Feb. 14,
2013), https://sciencebasedmedicine.org/who-takes-dietary-supplements-and-why/.
2

Falci L, Shi Z, Greenlee H., Multiple Chronic Conditions and Use of Complementary
and Alternative Medicine Among US Adults: Results from the 2012 National Health
Interview Survey (May 5, 2016),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858448/.
3

Anders Sven, Schroeter Christiane, The Impact of Nutritional Supplement Intake on
Diet Behaviour and Obesity Outcomes (Oct. 9, 2017),
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185258.
4

Bailey Regan L., Gahche Jamie J., Miller Paige E., Why US Adults Use Dietary
Supplements (Mar. 11, 2013),
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1568520.
5

Economic Impact of the Dietary Supplement, THE SCIENCE BEHIND THE SUPPLEMENTS,
https://www.crnusa.org/resources/economic-impact-dietary-supplement-industry.
6

Akabas, Sharon R. et al, Quality Certification Programs for Dietary Supplements, J. OF
116, Issue 9, 1378-79 (Sept. 2016).

THE ACAD. OF NUTRITION AND DIETETICS, Vol.
7

Bailey, supra note 4.
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disease.”8 Furthermore, “[t]he Government Accountability Office found that one
in five dietary supplements sold for weight loss or immune system support
included prohibited disease-related claims on their labels.” 9 Not only do such
claims entice consumers to purchase the products, but they also put an
unwarranted amount of risk on the consumer in putting their faith in the product
when professional medical help may be the most beneficial avenue. Consumers
often believe what they see on the label, and rely on those claims being made to
them – when in reality, at best, such products are often just a band aid on the
situation. 10 Not only is there the possibility of falsified claims being made by
manufacturers, but some companies have also contaminated their products with
filler that were not listed within the ingredients. This came to fruition when
investigators found powdered rice and laxatives in place of St John’s Wort, 11

8

Akshay Kapoor & Joshua M. Sharfstein., Breaking the Gridlock: Regulation of Dietary
Supplements in the United States, WILEY ONLINE LIBR. (Nov. 2, 2015),
https://onlinelibrary.wiley.com/doi/full/10.1002/dta.1892; see also CA Morris & J.
Avorn, Internet Marketing of Herbal Products, PUBMED.GOV (Sept. 17, 2003),
https://www.ncbi.nlm.nih.gov/pubmed/13129992.
9

Morris, supra note 8, see also Office of Inspector Gen., Dietary Supplements:
Structure/Function Claims Fail to Meet Federal Requirements, DEPT. OF HEALTH AND
HUMAN SERVICES DIETARY SUPPLEMENTS, (Oct. 2012),
https://oig.hhs.gov/oei/reports/oei-01-11-00210.pdf; see also Nadel Mark V., Committee
on Labor and Human Resources, https://www.gao.gov/assets/90/83193.pdf (“[T]his was
an issue even thirty years ago when dietary supplements were not widely used. From
fiscal year 1989 to 1992, FDA had taken action against about 290 companies that
manufactured or marketed dietary supplements. FDA took action against about 250 of the
companies because I determined that their products’ labelling contained unsubstantiated
drug claims and, thus, the products were new drugs that were misbranded. FDA took
action against the remaining companies because it considered the substances in their
products to be unsafe food additives because they were not generally regarded as safe and
had not been approved by FDA for use in foods or their products’ labelling did not
contain a complete list of ingredients.”)
10

See generally Bill Fay, Average Doctor Visit Cost, DEBT.ORG,
https://www.debt.org/medical/doctor-visit-costs/ (last updated Apr. 2, 2019).
11

Steven G. Newmaster, et al., DNA Barcoding Detects Contamination and Substitution
in North America Herbal Products, BMC MEDICINE (Oct. 11, 2013),
https://doi.org/10.1186/1741-7015-11-222 (“[H]erbal products available to consumers in
the marketplace may be contaminated or substituted with alternative plant species and
fillers that are not listed on the labels. According to the World Health Organization, the
adulteration of herbal products is a threat to consumer safety. Our research aimed to
investigate herbal product integrity and authenticity with the goal of protecting
consumers from health risks associated with product substitution and contamination.”)
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black walnut in place of Ginkgo biloba,12 and various species of Asian actae in
place of black cohosh.13
Nevertheless, strictly speaking about dietary supplements, consumers rely on
the claims on the label and put their faith into the stipulated ingredients because
they are not necessarily aware that dietary supplements - often sold within the
same vicinity as FDA approved over-the-counter drugs - are not tested for safety
or efficacy prior to market entry. 14 However, the perception of many is that
anything on sale within the same purlieu of those over-the-counter drugs are as
safe and as widely regulated.15
A. Weight-Loss Supplements
With the current obesity epidemic around the world, and particularly in the
U.S.,16 many Americans turn to supplements to aid and accelerate their weight
loss journey.17 The reason that many turn to supplements, is because not enough
doctors treat obesity as a disease, and even those who do, cannot prescribe drugs
Id., (Within the experiment, “[m]ost of the herbal products tested were of poor quality,
including considerable production substitution, contamination and use of fillers. These
activities dilute the effectiveness of otherwise useful remedies, lowering the perceived
value of all related products because of a lack of consumer confidence in them. We
suggest that the herbal industry should embrace DNA barcoding for authenticating herbal
products through testing of raw materials used in manufacturing products. The use of an
SRM DNA herbal barcode library for testing bulk materials could provide a method for
‘best practices’ in the manufacturing of herbal products. This would provide consumers
with safe, high quality herbal products.”)
12

13

Id.; see also DA Baker, et al., DNA Barcode Identification of Black Cohosh Herbal
Dietary Supplements, PUBMED.GOV, (last visited Sept. 8, 2019),
https://www.ncbi.nlm.nih.gov/pubmed/22970567.
14

Joanna K. Sax, Dietary Supplements are Not all Safe and Not all Food: How the Low
Cost of Dietary Supplements Preys on the Consumer, AM. J. OF L. & MED. (Sept. 21,
2015), https://doi.org/10.1177%2F0098858815591523.
15

Id.; see also U.S. FOOD & DRUG ADMIN., Mixing Medications and Dietary Supplements
Can Endanger Your HealthI, FDA,
https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm420349.htm (last updated
Oct. 27, 2014).
16

CTRS. FOR DISEASE CONTROL AND PREVENTION, Obesity is Common, Serious, and
Costly, CDC, (Aug. 13, 2018), https://www.cdc.gov/obesity/data/adult.html (“[T]he
prevalence of obesity was 39.8% among adults and 18.5% among youth in the United
States in 2015-2016. Obesity prevalence increased in both adults and youth during the 18
years between 1999-2000 and 2015-2016”); see also NAT’L CTR. FOR HEALTH AND
STATISTICS, Prevalence of Obesity Among Adults and Youth: United States, 2015-2016,
(Oct. 2017) https://www.cdc.gov/nchs/data/databriefs/db288.pdf (‘Obesity prevalence
increased in both adults and youth during the 18 years between 1999-2000 and 20152016.”).
17

Edward McKinley, As Obesity Rates in America Soar New Weight Loss Drugs are in
the Offing that Offer Hope, CNBC (Dec. 22, 2018, 9:00 AM),
https://www.cnbc.com/2018/12/12/new-obesity-drugs-are-coming-but-doctors-andinsurers-are-hurdles.html (“In general, the way obesity medication works is either by
affecting the brain or the gut. It can work on your brain to make you feel less hungry, on
your intestines and gut to make you digest food more slowly, or some combination of the
two.”).
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to all but their wealthiest patients; with few insurers, and no government insurance
program, offering coverage.18 In an industry-sponsored study, 3,500 Americans
were surveyed about their use of dietary supplements for weight loss.19 The results
of the study were worrying. A majority believed that not only were the weightloss supplements approved for safety and efficacy, but that these type of
supplements were actually safer than over the counter or prescription
medications. 20 Based on these findings, it is not surprising that thousands of
American’s are reluctant to seek medical advice about their weight and instead
rely on manufacturers who claim to be the quick fix that they are looking for.21
B. Dangers: Emergency Department Visits
The obese population are not the only ones at risk. A recent study published
in the New England Journal of Medicine found that adverse effects of dietary
supplements were responsible for an average of about 23,000 emergency
department (ED) visits per year. 22 Dietary supplements are best known for
providing benefits to the human body; they should not put an unjustifiable amount
of risk of those who are taking it. 23 Weight-loss products accounted for one
quarter of all single-product ED visits and disproportionately affected women,

18

Id.

19

See Janine L. Pillitteri et al., Use of Dietary Supplements for Weight Loss in the United
States: Results of a National Survey, WILEY ONLINE LIBR. (Sept. 6, 2012),
https://onlinelibrary.wiley.com/doi/epdf/10.1038/oby.2007.136 (One noticeable result
from the survey was that a higher proportion of African Americans and Hispanics used
dietary supplements than did whites and additionally, those with less education, lower
incomes, and no health insurance were more likely to use supplements. Finally, dietary
supplements were more likely to be used by those who reported a greater number of
lifetime weight-loss attempts, tried a greater number of weight loss products and
methods, and reported greater willingness to see a doctor for assistance with weight loss.)
20

Id.

Id., (“[C]ertain groups that were surveyed were more likely to believe that dietary
supplements are safe, efficacious, and regulated before marketing. These groups included
younger respondents (aged 18-24 and 25-34 years vs. older age groups); African
Americans, Hispanics, and other ethnicities (compared to whites); those with less
education; and those without health insurance.”)
21

22

Andrew I. Geller et al., Emergency Department Visits for Adverse Events Related to
Dietary Supplements, N. ENG. J. MED. 373;16 (Oct. 15, 2015),
https://www.nejm.org/doi/pdf/10.1056/NEJMsa1504267 (“[S]uch visits commonly
involved cardiovascular manifestation from weight-loss or energy products among young
adults and swallowing problems, often associated with micronutrients, among older
adults.”)
Id., (“[W]orryingly, unsupervised ingestions by children caused more than one fifth of
all estimated emergency department visits for supplement-related adverse events, with
almost two thirds involving micronutrients. Child-resistant packaging is not required for
dietary supplements other than those containing iron”); see also Susan Farrell., Harmful
Effects of Supplements Can Send you to the Emergency Department, HARV. MED. SCH.
(Oct. 15, 2015), https://www.health.harvard.edu/blog/harmful-effects-of-supplementscan-send-you-to-the-emergency-department-201510158434.
23
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while men were more likely to experience adverse effects from products
advertised for sexual enhancement and body building.24
Apart from rapid weight loss, dietary supplements are often marketed to those
individuals who work-out.25 These people are not looking for a quick fix in terms
of their health; rather they are looking for an increase in their performance. 26
Unfortunately, those in that position often are young adults,27 and as demonstrated,
those within that category are among the most likely to believe that dietary
supplements go through the same rigorous regulation and testing by the FDA as
do over-the-counter drugs.28
1.

Case Study: Matthew Dana

Unfortunately, that lack of knowledge had detrimental effects on a young
bodybuilder – Matthew Dana. In August 2017, Dana, a 27-year-old New York
State Sergeant died after overdosing on a dietary supplement common in the
bodybuilding field - Kratom.29 Known as an energizer and pain reliever, it has
been extensively used in the bodybuilding community to help lifters feel focused
and energized. 30 In 2017, Kratom was regarded as a dietary supplement and
24

Farrell, supra note 23.

25

Karimian, Jahangir, Esfahani, Parrivash S., Supplement Consumption in Body Builder
Athletes, J. OF RES. AND MED SCI. (Oct. 2011),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430026/ (In this study, a substantial
number of bodybuilders took vitamins, minerals, and/or other supplements. “Among
national-level Sri Lankan athletes, it was reported that 94% of the subjects had used
supplements. In University students in U.S., 89% used dietary supplements. Additionally,
like many other studies, men were more likely to take supplements than women.”)
26

Id.; see also Frolad K., Koszewski W., Hingst J., Kopecky L., Nutritional Supplement
use Among College Athletes and Their Sources of Information, INT’L. J. OF SPORT
NUTRITION AND EXERCISE METABOLISM (Oct., 2004),
https://www.ncbi.nlm.nih.gov/pubmed/15129934 (Reasons for supplement intake
include; include increasing energy, enhancing performance, improving health, prevention
of nutritional deficiencies, prevention of illness, increasing muscle mass, and improving
recovery.)
27

Kristiansen M., Levy-Milne R., Barr S., Flint A., Dietary Supplement use by Varsity
Athletes at a Canadian University, INT’L. J. OF SPORT NUTRITION AND EXERCISE
METABOLISM (Apr. 2015),
https://pdfs.semanticscholar.org/cbb8/351840c623cbe4f626b998f1e5b80735d983.pdf
(Among Canadians, 94.3% of young athletes were reported to have one or more
supplement use.)
28

CTRS. FOR DISEASE CONTROL AND PREVENTION, supra note 16.

29Danielle

Zickl, This Healthy 27-Year-Old Bodybuilder Died After Using a Common
Supplement, MENS HEALTH (Oct. 3, 2017), https://www.menshealth.com/trendingnews/a19537222/police-officer-matthew-dana-kratom-bodybuilding-supplementoverdose/.
Id.; see also Joel Balsam, Police Sergeant Matt Danas’s Death Ruled A Kratom
Overdose, ASK MEN (Oct. 2017), https://www.askmen.com/news/sports/police-sergeantmatt-dana-s-death-ruled-a-kratom-overdose.html (“In 2017, six states had banned
Kratom and the Drug Enforcement Agency considered making it illegal nationwide, but
decided to delay its decision in 2016 due to protests from Congress and the American
Kratom Association.”)
30
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therefore it had not been tested in the same clinical trials that other drugs are
subjected to. Ultimately that means that the dietary supplement world had no idea
exactly what would happen if someone were to take it over a long period of time
or ingest a lot of it.31 It was not until September 2018 that the FDA released a
statement regarding the ongoing concerns about the supplement.32 The Matthew
Dana death revived the movement for Kratom to be labelled as an illegal substance;
but this example shows that it should not require a death or a significant adverse
health effect for the FDA to respond to such dietary supplements before removing
them and banning them from production.33 This death could have been avoided if
the proper science and testing had gone into regulating the dietary supplement
before it was available to the public.
II.

THE FDA’S CURRENT REGULATION

Dietary supplements are classified as food. As defined in the U.S. Code, the
term dietary supplement means a product (other than tobacco) intended to
supplement the diet that bears or contains one or more of the following dietary
ingredients: a vitamin; a mineral; a herb or other botanical; an amino acid; a
dietary substance for use by man to supplement the diet by increasing the total
dietary intake; or a concentrate, metabolite, constituent, extract, or combination
of any ingredient described in clause (A), (B), (C), (D), or (E)34 The classification
as a food rather than a drug is a huge problem and is one of the major reasons why
the current standard in place is lacklustre when it comes to regulation, safety, and
efficacy. Being classified as food is important for the FDA because there is no
requirement that each supplement goes through the extensive regulatory process
that prescription drugs do. That is not to say that dietary supplements are
unregulated, and it is a free for all market - they are just not regulated to the degree
that they should be.

31Zickl,

supra note 29.

32

FDA Statement, Statements from FDA Commissioner Scott Gottlieb, M.D., on new
warning letters FDA is issuing to companies marketing Kratom with unproven medical
claims; and the agency’s ongoing concerns about Kratom (Sept. 11, 2018),
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620106.htm
(“[M]itragyna speciosa, known more commonly as Kratom, is a plant native to Thailand,
Malaysia, Indonesia and Papua New Guinea. There is evidence that certain substances
found in Kratom are opioids and data suggest that one or more may have a potential for
abuse. The FDA is not alone in its concern about the opioids found in Kratom – it’s
already illegal or controlled in several other countries including Australia, Denmark,
Germany, Malaysia and Thailand. The substance is also banned in a number of states and
municipalities in the U.S.”)
Nat’l Ctr. for Complementary and Integrative Health, In the News: Kratom (Mitragyna
species), NCCIH (Jun. 29, 2018), https://nccih.nih.gov/news/kratom (“[I]n June the FDA
completed its investigation of Kratom. However, because of proponents of the plant, the
banning of the substance all together did not carry forward. Therefore the FDA continues
to actively evaluate all available scientific information on the issue and continues to warn
consumers not to use any products labeled as containing the botanical substance Kratom
or its psychoactive compounds. According to the most recent statement by Commissioner
Gottlieb, the “FDA stands ready to evaluate evidence that could demonstrate a medicinal
purpose for Kratom; however, the agency has received no such submissions and is not
aware of any evidence that would meet the agency’s standard for approval.””)
33

34

See 21 U.S.C. § 321 ff (2010).
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A History of the Regulation

Prior to any legislation, dietary supplements were regulated under the general
food provisions of the FDA. “[T]he Pure Food and Drug Act of 1906 dealt with
unsafe foods, unregulated elixirs, and misbranded products.”35 In 1941 the FDA
promulgated the first recommended daily allowance regulations for vitamin and
mineral supplements and other foods for special dietary needs containing added
vitamins or minerals. “[However] these regulations placed no restriction on the
amount or variety of nutrients that could be included in a supplement or a fortified
food.”36 Furthermore, between 1962 and 1974, the FDA attempted to revise these
regulations to replace the minimum daily requirements (MDR), with a new
reference standard – the U.S. Recommended Daily Allowance (U.S. RDA) – and
to establish a standard of identity restricting the amounts of combinations of
vitamins and minerals that could be marketed as dietary supplements. The FDA
also “proposed to require a label disclaimer on vitamin or mineral supplements.”37
The nineties saw a huge reform and restructuring of dietary supplement
regulation. In 1990, “Congress passed the Nutritional Labelling and Education
Act (hereinafter ‘NLEA’), which affected the labelling of food and dietary
supplements. The significance of the NLEA was that it mandated that virtually all
food labels not only had to contain specific information on nutrient content, but
they could also make claims relating to specific diseases or disorders.”38 “In 1992,
Congress passed the Dietary Supplement Act which essentially prohibited the
implementation of NLEA with respect to dietary supplements except for the
approved health claims.”39
In 1994, Congress passed, and President Clinton signed, the Dietary
Supplement Health Education Act.40 The Act was established to “[t]o amend the
Federal Food, Drug, and Cosmetic Act to establish standards with respect to
dietary supplements, and for other purposes.” 41 In signing such legislation,
President Clinton stated:
After several years of intense efforts, manufacturers, experts in
nutrition, and legislators – acting in a conscientious alliance with
35

HEALTH.GOV, Report of the Commission on Dietary Supplements 11-17 (1997)
https://health.gov/dietsupp/final.pdf.
36

Id.

Id., (“The disclaimer would state: ‘Vitamins and minerals are supplied in abundant
amounts by commonly available foods. Except for persons with special medical needs,
there is no scientific basis for recommending routine use of dietary supplements.”)
37

Id., (“Such “health claims” were to be based on significant scientific agreement on the
validity of the claimed relationship between the nutrient and the disease. In response to
this, the FDA established standards for the types and levels of evidence necessary to meet
the criteria for approval of health claims.”)
38

Id., (“The following year the FDA published an extensive ANPR which was to
pinpoint the current standards of regulation in the use of dietary supplements. This ANPR
was a significant factor for the development and passage of the DSHEA in 1994.”)
39

40

Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat.
4325
41

Id.
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consumers at the grassroots level – have moved to successfully bring
common sense to the treatment of dietary supplements under regulation
and law.42
However, under the DSHEA, supplement manufactures still not need
demonstrate safety or efficacy; “rather, the DSHEA purposefully minimizes
oversight by the FDA and focuses on the value of the industry for the US
economy.”43
Manufacturers of dietary supplements containing ingredients that were
introduced after October 15, 1994, (the enactment date of the DSHEA), were
required to notify the FDA before marketing and to provide a rationale for the
safety of the ingredients, such as historical use. However, neither safety testing
nor FDA approval was required before the marketing of dietary supplements.44
For those ingredients that were introduced before October 15, 1994, dietary
supplement manufacturers were only responsible for establishing the safety and
quality of a product, but they were not required to share that information with the
FDA before the product entered the market. 45 Because the “FDA has limited
resources to ascertain harmful effects - products of dubious quality can stay in the
market without consequence.”46
It took until 2007 for a response when Congress finally passed the Dietary
Supplement and Non-prescription Drug Consumer Protections Act (DSNDCP).47
The law amended the Federal Food, Drug, and Cosmetic Act (FDCA) to require
manufacturers of dietary supplements to report serious adverse events to the FDA.
Prior to this law being passed, the FDA were under no obligation to collect adverse
health occurrences from the manufactures; the only information they had access
to respond to, was any complaints the public had put forward directly to the FDA.
However, the passing of the DSNDCP went further. As Senator Richard Durbin
said at the time, “[w]ith this bill, the FDA will have the tools to monitor

HEALTH.GOV, supra note 35 (“The new legislation defines dietary supplements, places
the responsibility for ensuring their safety on manufactures, identifies how literature may
be used in connection with sales, specifies types of statements of nutritional support that
may be made on labels, specifies certain labelling requirements, and provides for the
establishment of regulations for good manufacturing practices.”)
42

43

Ahar H. Bimal, The Dietary Supplement Health and Education Act: Time for a
Reassessment. Comment on “Acute Selenium Toxicity Associated with Dietary
Supplement,” JAMA NETWORK
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/415585 (Feb. 8, 2010).
New Dietary ingredients in Dietary Supplements – Background for Industry, FDA
http://www.fda.gov/Food/DietarySupplements/NewDietaryIngredientsNotificationProces
s/ucm109764.htm (last visited Oct. 4, 2019).
44

45

Jaap Venema, et al., Dietary Supplements Quality Analysis Tools from the United
States Pharmacopeia, DRUG TEST ANALYSIS
https://onlinelibrary.wiley.com/doi/full/10.1002/dta.1940 (last visited Mar. 2016).
46

47

Id.

Dietary Supplement and Nonprescription Drug Consumer Protection Act, Pub. L. No.
109-462, 120 Stat. 3469.
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supplements that cause dangerous health problems like heart attacks, strokes,
seizures, and liver failure.”48
In the same year, the FDA released regulations establishing standards for
Current Good Manufacturing Practices (CGMPs) for dietary supplements. At the
time, the current FDA Commissioner Andrew C. Von Eschenbach stated that the
regulations would “help to ensure the quality of dietary supplements so that
consumers could be confident that the products they purchase contained what is
on the label.”49
In 2011 the FDA released draft guidance that clarified what constituted a new
dietary ingredient requiring additional assurances of safety and streamlined the
necessary reporting structure. The agency’s press release called for “preventive
control to ensure that consumers are not exposed to unnecessary public health
risks from new ingredients with unknown safety profiles.”50 A worrying statistic
to note is that despite the FDA’s new requirement to register new ingredients,
even with the increase of 86,000 supplements on the market since 1994 when the
DSHEA was passed, only 170 notifications of new ingredients were received.51 A
majority of the market value is covered by only about 100 ingredients (e.g. fish
oil, calcium, glucosamine/chondroitin, CoQ10, and ginkgo), and major product
categories (e.g. multivitamins, sports nutrition, and probiotics).52
III.

THE METHOD’S ALREADY IN PLACE

In an ideal world, all manufacturers would follow the guidance, legislation,
and rules that has accumulated over the years. The responsibility is in the hands
of the manufacturer when it comes to the supplements themselves.53 Even with
the CGMPs and DSHEA, there are still three main areas left untouched; “(1) they
do not limit consumers’ access to dietary supplements; (2) they do not address the
safety of the supplements’ ingredients; and (3) they do not address the
48

R. Durbin, U.S. Senate Committee on Environment & Public Works: Durbin Dedicates
Dietary Supplements Legislation (2006),
https://www.epw.senate.gov/fact.cfm?party=rep&id=267066.
49

Press Release, FDA Issues Dietary Supplements Final Rule, (Jun. 22, 2007),
http://www.fda.gov/NewsEvents/Newsroom/PressAnnoucnements/2007/ucm108938.
50

U.S. Food and Drug Administration, Press Release: FDA Issues Anti-Smuggling
Strategy and Draft Guidance on New Dietary Ingredients (Jul. 5, 2011),
https://www.prnewswire.com/news-releases/fda-issues-anti-smuggling-strategy-anddraft-guidance-on-new-dietary-ingredients-125011839.html.
51

See generally Pieter A. Cohen, et al., Presence of Banned Drugs in Dietary
Supplements Following FDA Recalls, JAMA NETWORK (Oct. 22, 2014),
https://jamanetwork.com/journals/jama/fullarticle/1917421.
52
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Zickl, supra note 28.

Editorial Content Team, Manufacturing Guidelines for Dietary Supplements, U.S.
CANCER SOC’Y (Mar. 31, 2015), https://www.cancer.org/treatment/treatments-and-sideeffects/complementary-and-alternative-medicine/dietary-supplements/manufacturingguidelines.html (“Many manufacturers have always followed careful consistent standards
and sell only high-quality, correctly labeled supplements. But there are manufacturers out
there who are less careful and end up making supplements that contain little or none of
the products listed on the label. It is important to keep in mind that despite the continuous
accumulation of regulation many supplements are still found to be tainted with real drugs
or dangerous substances as not all manufactures follow the rules.”)
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supplements’ effects on the body as long as good manufacturing processes are
used.”54 The danger with these three areas left open, especially (2), is that criminal
manufacturers still have the potential to get their product onto the market as only
after it is on the market will the FDA have the power to remove it.
Honest manufacturers and those who pride themselves on standardized quality
do have options to show the consumers that they are doing all they can to remain
an integral part of the industry. Manufacturers can register with the United States
Pharmacopeial Convention (USP) - an independent, non-profit, scientific-based
organization, which has worked with volunteer experts from a wide cross-section
of stakeholders to develop and continuously revise and update science-based
quality standards for medicines, including their test methods and other tools that
help protect public health.55 Since 1992, USP has developed the science-based
quality standards for nutritional and dietary supplements following an open and
transparent public consultation process, whereby input from manufacturers,
regulators, suppliers, and any other interested party is considered and evaluated
by volunteer experts organized in expert committees. The USP admission
evaluation process involves consideration of safety information from multiple
sources, including adverse event reports from FDA MedWatch.56 The relevance
for consumers is that they can go into any store that the USP website lists as
having safe products with the awareness those products have been tested and have
gone through an assessment.57
The assessment is conducted for the sole purpose of determining whether or
not to develop a compendial monograph that is admitted in the United States
Pharmacopeia-National Formulary (USP-NF), however this is not intended as a
determination of the intrinsic safety or efficacy of the dietary supplement
ingredient or product under review. The USP-NF collaboration is recognised as
official compendia of the United States. 58 The USP-NF contains standards for
medicines, dosage forms, drug substances, excipients, biologics, compounded
preparations, medical devices, dietary supplements, and other therapeutics. Over
the counter drugs are required to be in compliance with these standards - whereas,

54

Id.
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U.S. Pharmacopeia, Dietary Supplements Compendium, USP
http://www.usp.org/products/dietary-supplements-compendium (last visited Oct. 9,
2019); see also U.S. Pharmacopeia, Dietary Supplements Verification Program, USP
http://www.usp.org/verification-services/dietary-supplements-verification-program (last
visited Oct. 9, 2019) (Dietary Supplement Verification Program Participants include the
following top manufacturers; Church & Dwight Co., Inc., Cyanotech Corporation,
MeriCal Inc., and Nutrawise Corporation).
56

USP, Guideline for the Admission of Dietary Supplement Ingredients to the USP-NF
Monograph Development Process (Feb. 5, 2017),
https://www.usp.org/sites/default/files/usp/document/get-involved/submissionguidelines/guideline-for-the-admission-of-dietary-supplement-ingredients.pdf.
57

U.S. Pharmacopeia, USP Dietary Supplement Verified, QUALITY SUPPLEMENTS,
https://www.quality-supplements.org/verified-products/verified-retailers (last visited Oct.
9, 2019) (Retailers that carry USP verified products include BJ’s Wholesale Club, Costco
Wholesale Club, HEB, K-Mart, Kroger, Meijer, Sam’s Club, Target, Walgreens and
Walmart.)
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Federal Food, Drug, Cosmetic Act, 21 U.S.C.S. § 321(j) (LexisNexis 2019).
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dietary supplements have the option. 59 It is unsurprising that many diet
supplement manufacturers typically avoid going through the USP-NF process to
avoid any risk of not meeting the compliance.
The importance of this process is that under the DSHEA, if a dietary
supplement manufacturer has gone through the USP-NF protocol and has gone on
to brand their product as doing one thing, but in fact it does not, then that dietary
supplement may be deemed misbranded because it has failed to comply with an
official compendium. 60 In essence, despite the good intentions from the DSHEA
in misbranding products that do not conform to the standards that they claim to
have under the USP-NF, they are just disincentivising manufacturers from going
through this process due to the risk of being misbranded. It is safer for them to
brand their product in getting as many purchasers as possible and waiting for them
to bring the product to the attention of the FDA.
IV.

WHY REFORM IS NEEDED

A. Unsafe Until Proven Safe vs. Safe Until Proven Unsafe
Today there is a disproportionate standard being applied to prescription/overthe-counter drugs and dietary supplements. Two out of the three have the
obligation to go through clinical processes, be certified by the official United
States Compendia, and to go through extensive testing to prove that what it says
on the label is in fact what the product contains/does. The combination of the
processes that prescription and OTC drugs have to go through ensure that what
the consumer is administering has in fact been proven to be safe for their health.
The outlier here is the lack-lustre regulation of dietary supplements. Since 1962,
the FDA has required that prescription drugs demonstrate safety and efficacy
through standard means of evaluation before they can be used by the public.61
Sixty years on and the FDA still does not require dietary supplements to go
through the same extensive testing as prescription or OTC drugs. Dietary
supplements are still labelled as a food despite being taken to have more of the
same effect as drugs rather than food.62 Considering a supplement unsafe until
proven safe is a standard that should have been cemented into the industry a long
time ago.63
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U.S. Pharmacopeia, Dietary Supplements & Herbal Medicines, USP
http://www.usp.org/dietary-supplements-herbal-medicines (last visited Oct. 9, 2019) (To
protect and improve their health, many people purchase dietary supplements and herbal
medicines over the counter – often assuming they’re regulated like drugs. While the law
requires pharmaceuticals to meet specific quality standards set by USP, the same
requirements don’t apply to supplements.)
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Zickl, supra note 28.
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Kefauver-Harris Amendments Revolutionized Drug Development, FDA (last modified
Oct. 10, 2012), https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm.
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Editorial Content Team, Drugs are Considered Unsafe Until Proven Safe, U.S.
CANCER SOC’Y (Mar. 31, 2015), https://www.cancer.org/treatment/treatments-and-sideeffects/complementary-and-alternative-medicine/dietary-supplements/fdaregulations.html (“[B]ecause supplements aren’t considered drugs, they aren’t put
through the same strict safety and effectiveness requirements that drugs are. So all the
drugs you can buy, even without a prescription, must be proven safe and effective – but
dietary supplements do not.”)
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Id., (This will all begin with the FDA changing their classification from food. This
paper is not to say that the classification should explicitly fall within the drug category,
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As more people reach for the easiest option when it comes staying healthy, the
Government and the FDA need to realise that categorizing dietary supplements as
food is neither suitable nor effective. This issue needs to be attacked with
aggression and force to protect the public. A stronger relationship with the FDA
is needed to establish a screening process that dietary supplement manufacturers
need to go through in order to get their ingredients tested and their products
labelled correctly in a similar way that drugs are.64 This paper is not setting forth
a requirement that dietary supplements go through the exact same protocols and
testing as drugs due to time and money/resource restraints. What this paper is
proposing is a happy medium – so consumers are aware of the side effects and the
FDA can continue to follow up on new products to see how they are performing
on the market.65
B. Current Drug FDA Regulation vs. Dietary Supplement Regulation
The time it takes for a new drug to get onto the market can be years. The
weight on the FDA’s shoulder’s is immense because the public are putting their
faith in the agency in making sure that what they are buying from the store or what
they are being prescribed by their doctor is safe and reliable to be taken in
accordance with their illness. The journey of a drug reaching the market “follows
a cyclical path of proposal, modification, and re-proposal until, finally, they reach
a decision on the product and create regulations.”66
The major difference between drugs and dietary supplements as, already
demonstrated, is that “the FDA only approves drugs if they are deemed both safe
and effective for their intended purpose.”67 Once a drug has been approved, the
FDA is “then responsible for regulating the drug which includes ensuring that the
but dietary supplements need to escape from the bubble that encompasses the same
regulations as food.)
64

Editorial Content Team, FDA Regulation of Drugs Versus Dietary Supplements, Drugs
are considered unsafe until proven safe, U.S. CANCER SOC’Y (Mar. 31, 2015),
https://www.cancer.org/treatment/treatments-and-side-effects/complementary-andalternative-medicine/dietary-supplements/fda-regulations.html (One the FDA approves
the drug, it must be manufactured under carefully monitored conditions and packaged
with complete information on the best dose, route, and schedule. The package
information must also include: conditions the drug has been proven to treat, known side
effects, contraindications (special conditions under which using the drug should not be
used because it would cause too much risk), and unsafe interactions with other drugs.)
65

Id., (Once the general public is using a new drug, the FDA follows up on any ill effects
patients and their doctors report. The drug company is required to file information they
get about side effects as well. This data helps ensure that any side effects not seen in the
clinical trials will eventually be found and tracked for the safety of other people.)
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Michael Moneheit, How the FDA Regulates Drugs, THE DOCTOR WEIGHS IN,
https://thedoctorweighsin.com/how-the-fda-regulates-drugs/ (last modified Aug. 26,
2016) (Before the FDA gets involved, scientists must develop and test a drug on animals,
after which point a drug company becomes involved to design a prototype of the drug.
The same drug company must then file an Investigational New Drug application with the
FDA. This is permission to hold clinical trials using humans. After completion of these
human trials, the research and all information gleaned from the clinical trials is submitted
to the FDA for final approval. If approved, the drug is then allowed to be marketed to the
general public.)
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Id.
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drug is labelled appropriately and isn’t causing adverse reactions with
consumers.”68 FDA regulation does not stop at approval; “there is also a multitiered activity level in place to provide continuous safety.”69
Dietary supplements are regulated – it is not a free for all market where
manufacturers can do what they please. The FDA is in charge of regulating dietary
supplements in many different ways. They do the following: (1) The FDA
monitors the marketing claims made by dietary supplement companies; making
sure that those companies do not claim that their products prevent, reduce the
symptoms of, or cure diseases. 70 (2) The FDA reviews and approves the
introduction of new ingredients to the market by affirming generally recognized
as safe (GRAS) status, or as new dietary ingredients (NDI).71 (3) If the evidence
indicates an ingredient is harmful, the FDA establishes supplement label warning
requirements and – if necessary – mandates removal of an ingredient from the
market place.72 (4) The FDA inspects manufacturing facilities to make sure that
they follow Current Good Manufacturing Practices (CGMPs). 73 (5) The FDA’s
CGMPs cover everything from raw material verification to finished product
testing and accurate labelling.74 CGMPs are the most efficient and effective way
in which the FDA manages to control supplements. 75 CGMPs do impose higher
standards and look to increase the likelihood that supplements are produced in a
quality manner and are accurately labelled.76
68

Id.

69

Id.; See also Susan Thual and Agata Dabrowska, How FDA Approves Drugs and
Regulates Their Safety and Effectiveness, CONGRESSIONAL RESEARCH SERVICE (2018)
https://fas.org/sgp/crs/misc/R41983.pdf (The FDA regulates new drugs through a multitiered activity record that takes into account: product integrity, labeling, reporting,
surveillance, drug studies, risk management, information dissemination, off-label use,
and direct-to-consumer advertising. From changes to the way the drug is marketed to
label changes or warnings to a drug being pulled from the market entirely, the actions of
the FDA control the fate of medications across the country.)
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The FDA and Dietary Supplements: How Supplements are Regulated, NOW
https://www.nowfoods.com/now/nowledge/fda-and-dietary-supplements-howsupplements-are-regulated (last visited Oct. 9, 2019).
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Id.
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Id.
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Id.
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Id., (“[W]hile the FDA expects manufacturers of dietary supplements to comply with
CGMPs, the FDA does not certify companies to be in compliance. Instead when the FDA
inspects a manufacturing facility, it will issue “observations,” identifying deficiencies.
The manufacturers then need to correct these deficiencies.”)
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Current Good Manufacturing Practice in Manufacturing, Packaging, Labelling, or
Holding Operations for Dietary Supplements, FED. DRUG ADMIN. (2010).
https://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/
dietarysupplements/ucm238182.htm (“[T]he DS CGMP rule requires persons who
manufacturer, package, label, or hold a dietary supplement to establish and follow current
good manufacturing practice to ensure the quality of the dietary supplement and to ensure
that the dietary supplement is packaged and labelled as specified in the master
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All of these regulatory techniques in place are great on paper, but they are
retrospective and only attack the problem once the problem is too large to tackle.
The FDA’s regulation of drugs attack the problem before the problem is there and
that is the difference. As it is explicitly stated on the FDA website, the ‘FDA is
not authorized to review dietary supplement products for safety and effectiveness
before they are marketed.’ 77 The manufacturers and distributors of dietary
supplements are responsible for making sure their products are safe before they
go to market. It is only if a serious problem associated with a dietary supplement
were to occur, must then manufacturers report it to the FDA as an adverse event.
The FDA can only take dietary supplements off the market if they are found to be
unsafe or if the claims on the products are false and misleading.78
C. Marketing Techniques: Drugs vs. Dietary Supplements
A comparison of the drugs and dietary supplements marketing efforts shows
the need to increase and heighten the current regulation in place before a
supplement will reach the market. In 2015, one recent analysis estimated that
manufacturers spent approximately $60 billion per year on such marketing,
including over $4 billion directed at consumers.79
For years, the FDA has been restricting manufacturers’ promotion of
prescription drugs in several important ways, including preventing manufacturers
from promoting their products to treat conditions for which the FDA has not
determined adequate efficacy or safety (off-label uses).80 However, despite the
requirement for dietary supplements to follow CGMPs, there are still loopholes
that manufacturers may wiggle their way through if they wish to get their product
into the market. The following case excerpt is a worrying example of how a
manufacturer is able to manipulate the loopholes in the supplement market.
1.

Amarin Pharma, Inc v. FDA

The facts of the case are pretty simple (especially given it is a drug regulation
dispute). In 2012, the pharmaceutical manufacturer Amarin received FDA
approval for a new drug, Vascepa, as an adjunct to diet to reduce triglyceride
levels in adult patient with severe hypertriglyceridemia.81 Following the approval,
manufacturing record. Dietary supplements containing contaminants or those not
containing the dietary ingredient represented on the label would be considered adulterated
or misbranded by the FDA.”)
77

Dietary Supplements: What You Need to Know, FDA (Nov. 2011),
https://www.fda.gov/Food/DietarySupplements/UsingDietarySupplements/ucm109760.ht
m.
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Lexchin, The cost of pushing pills: A New Estimate of Pharmaceutical Promotion
Expenditures in the United States, PLOS MED. 5(1): E1. (2008)
https://doi.org/10.1371/journal.pmed.0050001.
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Aaron Kesselheim, et al., Mandatory Disclaimers on Dietary Supplements Do Not
Reliably Communicate The Intended Issues, 34 HEALTH AFF. (Mar. 2015).
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Amarin Pharms. Ir, Ltd. v. FDA, No. 15-5214, 2015 U.S. App. LEXIS 21333 (D.C.
Cir. Dec. 9, 2015).
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Amarin designed and then discussed an additional two trials to see if Vascepa
effected triglyceride levels among statin-treated patients with persistently high
triglycerides and if it actually reduced major cardiac events. The latter trial was
denied by the FDA and they rescinded its prior agreement to allow Amarin to
market the drug as doing so. The FDA notified Amarin that any effort to market
Vascepa for this unapproved use could constitute misbranding under the FDCA.
Amarin took the FDA to court, seeking a preliminary injunction preventing the
agency from taking any action against the company for truthful, non-misleading
promotion of Vascepa to health care professionals for patients with persistently
high triglycerides and it won. The FDA’s concern is with off-label promotion by
pharmaceutical companies, and it has taken the position that such promotion
violates the FDCA, even though there is no such proscription in the Act itself. It
does so by reasoning that off-label promotion amounts to misbranding the drug.
Without getting into the merits of the case, what really needs to be taken from
this decision was what the FDA stated in their argument. Counsel for the FDA
said that, if Amarin repackaged Vascepa as a dietary supplement – Vascepa is
essentially fish oil -the FDA would not object to including the coronary heart
disease claim, on certain conditions. What the FDA were saying was that Amarin
could not promote it to doctors by making truthful coronary heart disease claims,
but selling it directly to consumers on that basis would be just fine. The Court
agreed that if Amarin were to label their dietary supplement with a coronary heart
disease claim, then they would not expose themselves to liability for misbranding
under the pharmaceutical protocol. As long as Amarin would place a disclaimer
on the dietary supplement label, then they would be in the clear.
This case shows the purely illogical rationale behind the FDA and the
regulations in place for dietary supplements when compared to the exact same
ingredients and products under the pharmaceutical umbrella. Amarin portrays a
huge loophole in the system and a clear indication as to why so many
manufacturers can get their product into the market – potentially harming a huge
amount of people.
In response, this paper calls for dietary supplements to go through a multitiered screening and testing process (similar to prescription drugs), meaning gaps
like the one shown in Amarin can be avoided. This paper calls for a two-step
process that addresses how dietary supplements reach the shelves. The public can
be re-assured of the safety and efficacy of what they are taking on a day to day
basis.
D. Product Labelling Claims
Despite not being taken as a replacement for prescription drugs; dietary
supplements are used to boost general health, and to ward off illnesses.82 However,
several met-analyses of rigorous efficacy studies report that dietary supplements
are not effective in either treating or preventing disease. 83 Although certain
supplements can prevent or treat specific ailments – for example, calcium plus
vitamin D has been approved to treat osteoporosis – it is unclear whether many
other supplements offer real health benefits to those without nutrient
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Reasons of U.S. Consumers to Take Vitamins, Minerals and Nutritional supplements as
of 2012, STATISTA http://www.statista.com/statistics/308645/reasons-us-consumers-usevitamin-mineral-nutritional-supplements/ (last modified Dec. 1, 2012).
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deficiencies. 84 Unsubstantiated product-benefit claims in the advertising of
supplements are driving the market in to the ground, while the pharmaceutical
market is able to stay afloat due to the stringent regulations supporting it.85
E. Claims Being Made
Typically, supplement manufacturers will make two types of benefit claims in
advertising their product for the public.
Firstly, they state health claims. Health claims describe an established
scientific relationship between supplement ingredients and a reduction in the risk
of a disease or health-related condition. 86 These health claims have a
substantiation standard applied, meaning competent and reliable scientific
evidence has to be proven.87 Eventually the health claim has to be evaluated and
authorized by the FDA prior to marketing.88
Dietary Supplements are then allowed structure-function claims - regulated by
21 U.S.C. § 3434(a)(1) and 21 U.S.C. § 3434(r)(6)(13). Structure-function claims
describe the intended benefit of the supplement on the structure or function of the
body.89 These claims are the ones that are driving the dietary supplement market
into the ground because they do not bear the same high evidentiary burden and do
not require FDA approval prior to marketing.90 The FDA lacks the authority to
review or approve these claims before the products enter the market. A
manufacturer must notify the FDA when it uses structure-function claims, and a
product label must include a disclaimer stating that FDA has not reviewed the
claim and that the product is not intended to diagnose, treat, cure, or prevent any
disease.91
However, if a public survey were to be taken to see whether they actually took
this disclaimer into consideration, then the majority would answer no. 92 The
reason being is that they see the bottle or the tub of pills/powder on the shelves of
well-established stores and automatically think that because the store is selling the
product, then the entirety of the product must have gone through some
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testing/regulation. The plethora of information about dietary supplements at point
of purchase and in the media is also often unclear, unreliable, and conflicting.93
F. Availability of Dietary Supplements
The place of purchase is another aspect to take into consideration because of
the freedom they have in selling such products. Stores such as GNC and The
Vitamin Shoppe are everywhere and provide instant access to thousands of
products that are safe, but at the same time the opportunity is there for unsafe
products with misleading claims to find their way onto the shelves. 94 Although
GNC started in 1935 and The Vitamin Shoppe opened its doors in 1977, it has not
been until the last few decades that they have both seen a real surge in customers.
Dietary supplements were once only associated with bodybuilders, strongmen,
and professional athletes. The average Joe felt no inclination to take them. It was
seen as if they were only necessary if you were about to step on the stage at the
Mr. Olympia. However, as the years have passed and social media has developed,
people have now started to take supplements upon waking, during work, with their
food, and before bed – 2019 is a time where the tables have turned. It is seen as a
rarity if you are not taking at least one form of dietary supplementation. Stores
such as GNC and The Vitamin Shoppe have taken advantage of the ‘less-informed’
consumers by not only selling uncertified products in their store, but also failing
to advise those consumers of the adverse effects what may arise upon extended
use.95
1.

Hubert v. Gen. Nutrition Corp.

In 2017, a class action lawsuit was brought against GNC alleging that they
knowingly sold products containing unlawful synthetic chemicals to consumers. 96
In Hubert, Plaintiffs alleged that GNC marketed and sold supplements
manufactured by third party vendors which allegedly contained Picamilon,
BMPFA or acacia rigidula, despite having known that these substances are not
dietary ingredients.97 The supplements at issue in Hubert, are primarily weightloss and sports nutrition supplements available as powders and liquids. Plaintiffs
averred that federal and state law place primary responsibility for the safety of
93

Sharon Akabas, et. al, Quality Certification Programs for Dietary Supplements, 116 J.

OF THE ACAD. OF NUTRITION AND DIETETICS 1370, 1372-1379 (2016).
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Company Overview, GNC, https://www.gnc.com/company-overview.html (last visited
Oct. 9, 2019) (GNC has more than 4,800 retail locations throughout the United States –
including more than 1,000 franchise and 1,200 Rite Aid store-within-a-store locations and
franchise operations in 46 international markets); See also About the Vitamin Shoppe,
THE VITAMIN SHOPPE, http://investors.vitaminshoppe.com/corporate-profile (What began
as a single store in 1977 has evolved into more than 700 locations in 42 states, the
District of Columbia and Puerto Rico and an easy to shop web site.)
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(Blame is not imputed to GNC and Vitamin Shoppe but the reason that they are
allowed to sell such products is because they have not been succumbed to the same
testing as is required for drugs. It can be dangerous with the public spending hundreds of
dollars at a time on such products and them not getting the instant results that they always
require.)
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dietary supplements, as well as truthful labelling and advertising, on supplement
manufacturers and distributors such as GNC. According to Plaintiffs, GNC sold
products with false and misleading labelling, and further failed to disclose
material facts about the dangers of ingesting Picamilon, BMPEA, and acacia
rigidula to consumers. Plaintiffs claimed that they were “hoodwinked” into
purchasing supplements containing these substances and would not have done so
if GNC had disclosed that they contained mislabelled ingredients which
purportedly pose serious health risks and are not marketable as dietary
supplements.98 The lack of FDA regulation is pivotal to the case - both for the
Plaintiffs and the Defendant. In 2015, Dr. Cara Welch of the FDA issued a
declaration stating that “Picamilon does not qualify as a dietary ingredient under
the FDA act.99 Part of Plaintiffs claim is that they alleged GNC continued to sell
dietary supplements containing Picamilon until September 21, 2015; despite
having known since 2007 that it was not a dietary ingredient.
In terms of acacia rigidula and BMPEA, Plaintiffs further claimed that GNC
had been aware since the 2013 that some dietary supplements labelled as
containing acacia rigidula actually contained BMPEA. The significance of this is
that FDA researchers conducted a study which revealed that many dietary
supplements purportedly containing acacia rigidula actually contained BMPEA,
despite no testing to show that BMPEA was safe for humans.100
Plaintiffs averred that despite GNC’s alleged knowledge regarding Picamilon,
BMPEA, and acacia rigidula, GNC sold products containing those substances
which were supplied by third-party vendors. Plaintiffs claimed that GNC
exercised significant control over the third-party products it sold by reviewing and
pre-approving labels, warnings, packaging and advertising. By controlling the
product labels of third party vendors, Plaintiffs alleged that GNC misrepresented
that supplements containing Picamilon, BMPEA, and acacia rigidula were safe
for consumers and legal to sell. 101 As a result, Plaintiffs asserted that they
purchased supplements they otherwise would not have purchased, paid more for
supplements than they otherwise would have paid and have been subjected to
unreasonable safety risks.102
The significance of this case reiterates the FDA’s lack of control from the
moment a dietary supplement is manufactured right through until it is sitting on
the shelves of an international store.103 Despite the case being dismissed, it shows
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of a lack of injury-in fact. The court found several arguments from the Plaintiffs’ to be
lacking. Noticeably the court rejected the argument that GNC sold products with false
and misleading labels and did not disclose material facts. The court stated that “the
complaint did not allege what those material facts allegedly were or even whether GNC
had an obligation to so disclose. The complaint also did not allege that the consumers
were induced to purchase the dietary supplements based on any specific
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a gap in the industry that needs to be altered in a way to stop companies like GNC
from taking advantage of the consumer.
According to the FDA, Picamilon is a substance that does not meet the
statutory definition of a dietary ingredient. Picamilon is a unique chemical entity
synthesized from the dietary ingredients niacin and gamma-aminobutyric acid.
Picamilon is absorbed into the body, crosses the blood-brain barrier and
accumulates in the brain as a separate chemical entity. Because Picamilon does
not fit any of the categories of dietary ingredients under the Act, any products
marketed as dietary supplements that declare Picamilon as a dietary ingredient are
misbranded.104
Acacia rigidula is different to Picamilon because it is a new dietary ingredient.
Acacia rigidula is labelled as a dietary ingredient in some products marketed as
dietary supplements. However, the FDA is unaware of any information that it was
lawfully marketed as a dietary ingredient in the United States before October 15,
1994. Due to the fact there is no history of use or other evidence of establishing
that the dietary ingredient, when used under the conditions recommended or
suggested in the product labelling, will be safe for consumers, the product is
deemed to be adulterated.105
Finally, BMPEA is also a substance that does not meet the statutory definition
of a dietary ingredient. While it was listed as a dietary ingredient on the product
labels (within GNC), BMPEA does not meet the statutory definition of a dietary
ingredient.106
The significance of this class action lawsuit being filed is that under existing
law, including the DSHEA passed by Congress in 1994, the FDA can take action
to remove products from the market, but they must first establish that such
products are adulterated or misbranded. 107 The publicity that this lawsuit has
subsequently caused should prove to be the ignition that is needed to get such
dangerous products off of the shelves which are so easy for consumers to buy.
The FDA is not the sole regulator and that is the issue in the Hubert case.
Given the size and diversity of the products and ingredients, the rapid pace with
which new dietary supplements are introduced into the market, and the fact that
FDA approval is not required before products are introduced to the market,
manufactures can get around the obstacles far too easily.

misrepresentation. Nor did it allege that GNC identified its product as superior or identify
comparable less expensive products to support an argument that an economic injury
existed in the form of premium prices paid for the GNC supplements.”).
104

Picamilon in Dietary Supplements, FDA (Nov. 29, 2017),
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm472881.htm.
105

Acacia rigidula in Dietary Supplements, FDA (Nov. 29, 2017),
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm489921.htm.
106

BMPEA in Dietary Supplements, FDA (Nov. 29, 2017),
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm443790.htm.
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G. Third-Party Certification Programs
As noted, there are independent third-party certification programs that offer
quality assurance for dietary supplements in the market place. 108 However, thirdparty certification/verification programs are not universally used by the dietary
supplement industry; they are fee-based programs and participation is
voluntary.109
ConsumerLab.com, NSF International, and US Pharmacopeial Convention are
three of the largest and most notable third-party organizations who test dietary
supplements as finished products - pills, powders, liquids, drinks, and sport and
energy products. 110 Quality certification by these companies ensure that these
supplements do not contain harmful levels of toxic botanical species, or greater or
lesser amounts of active or marker compounds than indicated on the product
specification and label. NF-USP was discussed earlier in this paper which leads
to the importance of ConsumerLab.com.
Starting in 1999, the ConsumerLab.com Quality Certification Program was
the first national third-party verification program for dietary supplements. 111 A
difference of the ConsumerLab.com is that it does not accept products directly
from the manufacturer; instead it purchases products from the marketplace and
the products must comply with FDA labelling requirements, must disclose
necessary information about each ingredient (such as the correct plant name and
plant part in botanical products), and can only display allowed product claims.
Although the results of these tests (pass or fail) are proprietary and confidential to
the manufacturer; if the product meets test standards, manufacturers can license
the use of the ConsumerLab.com seal of approval to use on their product labels,
packaging, advertising, and marketing. However, in order to continue to carry the
CL Seal directly on product labelling, the product must pass retesting every twelve
months.112 One thing extraordinary about ConsumerLab.com is that it indicates
when the recommended serving size for a nutrient exceeds the Tolerable Upper
Intake Level established by the Institute of Medicine of the National Academies.
The alternate to ConsumerLabs.com is NSF International. According to the
website, manufacturers, regulators and consumers look to NSF International for
the development of public health standards and certification programs that help
protect the world’s food, water, consumer products and environment.113 Like a CL
Seal, NSF International has a mark on products that have been tested and
subsequently passed the procedure. The NSF mark is the assurance that the
product has been tested by one of the most respected independent certification
organizations in the world. It means that the product contains the ingredients listed
on the label in the declared potency and amounts; it does not contain harmful
levels of specified contaminants, including >200 athletic banned substances for
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U.S. Pharmacopeia, supra note 57.
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The NSF Mark, THE PUB. HEALTH AND SAFETY ORG. http://www.nsf.org/about-nsf/nsfmark (last visited Oct. 9, 2019).
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Certified for Sport products, and it has been manufactured according to FDA’s
current CGMPs.114
These third-party certification programs are not mandatory for manufacturers
of dietary supplements to follow.115 It is therefore no wonder that cases such as
Hubert are being brought forward against large stores such as GNC. It is all too
easy for manufacturers to mislabel their products, as the chances of them being
caught by consumers is low. People generally do not go into a store searching for
ingredients that they know are banned. They merely see what they want on the
TV or on the Internet, and then proceed to their local supplement store. On the
other side of the spectrum is the blind eye that these stores show towards the array
of supplements that come through their doors. As illustrated by the Hubert case,
GNC do not have a protocol in place to wire out any misbranded supplements.
Assuming that The Vitamin Shoppe have similar standards in place, that means
that every general American wishing for that quick fix will generally have no
inclination that they may end up buying a product that could be detrimental to
their health. The employees are at no duty to warn customers of the effects,
because they too have no idea whether an ingredient is banned or whether a dietary
supplement has conformed with the FDA’s regulation protocol.
V. THE PROPOSAL
A new form of regulation; one that takes the pressure away from the FDA
needs to be established. The public is at the risk of continuous danger as the
market continues to grow. A multi-tiered regulating system is needed to ensure
that the public - who are currently being preyed on by manufacturers – can be
confident that what they are putting into their body has been tested, tested, and
tested again before they ingest.
Currently, consumers like the freedom in being able to ‘one-click purchase’
vitamins, powders, and pills from an array of websites. A majority of the public
believe that the government do not, and should not decide what can and cannot be
on the market, and that consumers should have some say in the process. 116 Many
believe (especially individuals who take supplements day in and day out), that if
a supplement were to be really harmful, then the market will eventually speak and
there will be no demand for it.117 The counter-argument on the other side of the
spectrum is that if there were to be no regulation what so ever, then consumers
may be harmed by the ingestion of harmful supplements.118 This follows on from
the idea that they need to be regulated in a way that is very similar to prescription
and OTC drugs.
Imagine living in a world where manufacturers such as Pfizer Consumer
Products (a major pharmaceutical company), had the option of getting pills such
as ‘Advil’ or ‘Viagra’ onto the market through a lack-lustre testing regime that
had no implications what so ever. Would the public still feel inclined to reach for
their dose of Advil to help combat an inflammation? Or would they be so willing
to reach for a ‘Viagra’? The answer to these two example questions are
114
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undoubtedly no. But if you were to switch the variables around and replace ‘Advil’
and ‘Viagra’ with ‘Pre-Workout Powder’ and ‘Weight Loss Pills’ then because of
the freedom that consumers have on the market, they will be more willing to try
the product despite them not going through the same testing process as the
NSAID’s and sexual enhancers. Just as the FDA is charged with securing a safe
food and drug supply, the FDA should have the same ability to ensure a safe
dietary supplement supply.119 A somewhat distant analogy can further be made
with cigarettes. Consumers want the autonomy and freedom to purchase as many
cigarettes as they want, all in the face of the data that demonstrates the lifethreatening health risks that they pose. Cigarettes go through extensive regulation,
yet consumers still enjoy the autonomy. Dietary supplements on the other hand
go through about half of that regulation, yet consumers still want and are able to
enjoy the same autonomy and freedom.
A. The Classification Phase
Currently, the FDA’s definition of Dietary Supplements includes a wide array
of products that many people may feel to be overwhelming. 120 For example, a
supplementary Vitamin C tablet has far less ingredients than a ‘pre-workout’
supplement.121 Until recently, Jack3d was a popular pre-workout among bodybuilders and college gym goers who wanted that crazy boost of energy. 122 With
no relative comparison, it is crazy to think that these two should go through the
same testing/regulation process. This is an example of why in the future, although
the term “Dietary Supplement” as used by the FDA is the catch all phrase, those
within that category, need to be split up into separate divisions so that they can be
regulated accordingly. The disparity in the repercussions of ingesting ascorbic
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Dietary Supplement Products & Ingredients, FDA (Nov. 20, 2018),
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/default.htm (The
Federal Food, Drug, and Cosmetic Act “defines a dietary ingredient as a vitamin;
mineral; herb or other botanical; amino acid; dietary substance for use by man to
supplement the diet by increasing the total dietary intake; or a concentrate, metabolite,
constituent, extract, or combination of the preceding substances.”)
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Chad Bjorklund, Ingredients of Vitamin C Tablets, LIVESTRONG,
https://www.livestrong.com/article/285497-ingredients-of-vitamin-c-tablets/ (“[W]hile
particular formulations of vitamin C tablets may differ slightly among competing
manufacturers’, the primary ingredient should be raw ascorbic acid. Vitamin C tablet
makers utilize raw ascorbic acid that is either extracted from plants like corn, or
chemically synthesized. Those Vitamin C tablets that do not have ascorbic acid as the
primary ingredient are marketed as special vitamins or multi-vitamins. However,
consumers should be aware of the filler ingredients. Filler ingredients may include but are
not limited to: vegetable or magnesium stearate, methylcellulose, glycerol and silica.
These agents are considered non-active ingredients because they are not expected to have
any negative or positive impact on your health.”)
Jack3d Ingredients, JACK3D http://www.jack3d.org/ingredients (The famous ‘lethal’
pre-workout ingredients were: arginine Alpha-Ketoglutarate, Creatine Monohydrate, Beta
Alanine, Caffeine, 1,3-Dimethylamylamine HCL, Schisandra Chinensis Extract, Citric
Acid, Silicon dioxide, Acesulfame Potassium, Sucralose, Vegetable Stearate, and Beta
Carotene.)
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acid123 as compared to dimethylamine is worrying.124 This incongruence calls for
vitamins and minerals etc., to go through alternate testing regimes. Whereas
supplements which have the potential to have the same effect as amphetamines
should obviously go through more rigorous testing to ensure that the standards
being met are of the highest degree. The difference in testing is for two reasons:
(1) consumer safety and (2) consumer awareness. Ascorbic acid can be tested
relatively quickly and efficiently. Dimethylamine on the other hand would require
a larger subject group because of the detrimental effects that it may induce.
This paper recommends that there be five tiers within this first ‘classification’
phase. Tier one being the lowest form of testing and tier five having to go through
a laborious period which could delay the product from reaching the shelves for
months and even years. Manufacturers must submit what they feel their product
is before any testing is done. Once manufactures have submitted their preferred
tier, those in charge of testing at the designated organization shall look to the
current side effects of each ingredient within the proposed supplement and
determine based on the severity of such side effects, whether that tier is applicable.
When submitting their preferred tier, a manufacturer must provide testing
methodology to support their position. Alternatively, if they fail to provide such
evidence, then their product will automatically be placed into tier five for the sake
of protecting the public.
Any products which have already shown a significant relationship with death,
abnormalities in child birth etc., will automatically be banned from ever being
administered into phase one. Again, this is purely for the safety of the consumer,
as for too many years they have been the scapegoat for many companies. The
FDA has been making blind choices; for example, when they see ingredients such
as dimethylamine on a tub of pre-workout that is labelled as “the best pump
guaranteed,” they quickly disengage the doubt and adhere to whatever the label
says.
B.

Post-Classification Tier for Testing

Once manufactures have been placed into the tier for their product to be tested,
they must then decide and further prove what category of dietary supplements
they wish to be defined as. Categories include but are not limited to: bodybuilding
supplements, energy drinks, energy food products, nutritional supplement
companies, relaxation drinks, sports nutrition and body supplements, and vitamins
and minerals.125 If a manufacturer does not fit into one of these categories, they
must then establish the category that they wish to defined under – again supported
by scientific data.126
123

Vitamin C, OFFICE OF DIETARY SUPPLEMENTS
https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/ (last visited Oct. 9, 2019)
(Vitamin C, also known as ascorbic acid, is a water-soluble nutrient found in some foods.
n the body, it acts as an antioxidant, helping to protect cells from the damage caused by
free radicals. Free radicals are compounds formed when our bodies convert the food we
eat into energy.)
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Avery, supra note 84 (For example, multiple deaths have been associated with a workout booster called “Jack3d,” which contains dimethylamine, described by the medical
literature as a synthetic stimulant similar to amphetamines.)
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Dietary Supplements, WIKIPEDIA
https://en.wikipedia.org/wiki/Category:Dietary_supplements (last visited Oct. 9, 2019).
Id.; see also Dietary Supplements for Weight Loss, NAT’L INSTITUTE OF HEALTH
https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/ (last visited Oct. 9,
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The reason for this classification is the transparency that such would bring to
the consumers. On the labelling for each product would indicate which tier that
the product is in. If a pre-workout supplement is in Tier four within the first phase
and under “bodybuilding supplement” in the second phase, then that is exactly
what is to be shown to those who will be buying such a product.
C.

Labelling Requirement

The ingredients and the effects of the supplement on the body are only a
portion of why someone ends up buying it. The other half is the marketing and
how such a supplement has been branded to the public. The government’s right to
restrict off-label promotion has been the subject of criticism in the past. 127 This
was amplified in US. v. Caronia, a Federal Circuit Court of Appeals case. 128 Under
the DSHEA that was passed in 1994, there is somewhat of a combative measure
against frivolous claims because health-related statements made for dietary
supplements must be accompanied by a standard disclaimer: “This statement has
not been evaluated by the Food and Drug Administration. This product is not
intended to diagnose, treat, cure, or prevent any disease.” 129
Not only will this statement be no longer needed with this reform, but any
statement that has not been evaluated by the governing body will not be sold under
the umbrella that is dietary supplements. All statements must be evaluated and
proven by the determined organization and the manufacturer respectively.
D.

The Federal Trade Commission’s Role

Currently the FTC regulates dietary supplement advertising; it has the primary
responsibility for monitoring claims in advertising, including print and broadcast
advertisement, infomercials, the Internet, catalogues, and similar direct marketing
materials.130 Because the FTC and FDA have shared jurisdiction for advertising
claims, they often work together on enforcement activities. This should not be a
requirement. This reform recommends a deviation from all of the different

2019) (For example, “if a manufacturer were to list their supplement in the ‘Weight-Loss’
category, they must be able to prove that active weight loss ingredients such as: African
mango (irvingia gabonensis), beta-glucans, bitter orange, caffeine, calcium, capsaicin,
carnitine, chitosan, chromium, coleus forskohlii, conjugated linoleic acid, fucoxanthin,
garcinia cambogia, glucomannan, green coffee bean extract, green tea, guar gum, hoodia,
probiotics, pyruvate, ketones, vitamin D, Phaseolus vulgarius and yohimbe are not
combined with other active ingredients that mask the effects such as benzodiazepines and
anti-depressants which mask the side effects of those listed stimulants within the same
pill.”)
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Kesselheim, FDA Regulation of Off-Label Drug Promotion Under Attack, 309 JAMA
445 (2013) https://www.ncbi.nlm.nih.gov/pubmed/23385267.
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U.S. v. Caronia, 703 F.3d 149 (2nd Cir. 2012) (the Court held that the First
Amendment of the US Constitution protects off-label promotion by manufacturers and
their sales representatives as a form of commercial speech, as long as the marketing is not
overtly false or misleading.)
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Regulations on Statements Made for Dietary Supplements Concerning the Effect of the
Product on the Structure or Function of the Body, 65 Fed. Reg. 1000, 1001 (Jan. 6, 2000)
(to be codified at 21 C.F.R. pt. 101).
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organisations with the sole responsibility embedded into one. By requiring
manufacturers to support that their label does what it says to a high percentage of
certainty will give the FDA and the FTC some breathing space. Requiring proof
to be submitted before the product goes on sale will lower the amount of frivolous
claims being made by individuals who often moan about the 10lbs not being lost
in 10 days. Such claims will not be made as often because such assertions will not
be authorised to be on a bottle of weight loss pills unless a reliable study has
shown that such an effect is highly probable.
The current situation of the market allows for the companies to make
advertisements and statements pointing to certain side effects. This is because in
1998, the Federal Trade Commission published a guidance document that
contained nonbinding recommendations that advertisements need not meet any
preapproval standard.131 The difficulty in there being no “black letter law” for
regulators or the industry to follow is that when dealing with a claim, courts have
so much discretion in deciding whether an advertisement claim is misleading or
not. What courts have to decide between is the First Amendment rights of a
company versus the “potential”, “weak, non-individualized injury suffered by the
plaintiff.” It is of no surprise that in recent years, courts have shifted from a
position of protecting the consumer to now favoring the supplement manufacturer
and marketer.132 What is remarkable is that courts often find the First Amendment
to prevail in such situations because they feel that inconclusive, unsupported
health claims are not enough to meet the ‘misleading’ threshold. If a company
places a disclaimer, then they are to be protected by commercial free speech
despite the disclaimer being used in support of an unsupported claim.133
E.

Disclaimer Requirement

As demonstrated, manufacturers currently have a duty to place a disclaimer on
their product to ensure that they are not “misleading” the consumer. However, this
is somewhat of an oxymoron because the disclaimer is being used as a safety net
for the statement that is misleading in general. They do it in such a way to cover
their tracks and to relinquish any liability if someone were to be negatively
affected by taking their supplements. How often have you seen the statement on
a tub of protein or a container of vitamins that says, “This statement has not been
evaluated by the Food and Drug Administration. This product is not intended to
diagnose, treat, cure, or prevent any disease.” An example of an untested product
using such a claim would be on any weight loss pill. If the statement on the front
said – “this product promotes healthy weight loss,” then this is suitable under
current regulations. However, because it has not been tested it cannot say that
“this product will lose you pounds.” The manufacturer would only have to add
that disclaimer to the bottle and now the supplement industry has won in being
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able to state that an untested product promotes health weight loss merely because
it contains a disclaimer. People are unaware that the disclaimer used means that
these products are not in fact drugs, and do not carry the same level of regulation
by the FDA, nor likely the same weight of scientific evidence.134 A disclaimer
signals to the consumers that it is up to them whether they want to take that
supplement and up to them whether they believe the product will benefit their
health and is safe for them to take.135 A disclaimer provides that the government
– specifically the FDA – does not vouch for its effects, but it is not saying that the
supplement does not work at all.
In a study conducted by the Associate Professor of Medicine at Harvard
Medical School, a survey was propounded upon the public to get their take and
beliefs on what a disclaimer on dietary supplements really does – or what they
believed it to do. Three example questions were very consistent with the points
that have already been made in this paper. (1) Question: Do supplement users have
differing perceptions of safety, efficacy, and regulatory oversight of dietary
supplements than nonusers? (1) Answer: Despite the presence of a disclaimer,
approximately 50% of respondents believed the FDA approves dietary
supplements for safety and efficacy. Younger respondents, minorities, and less
educated respondents were more likely to misunderstand the FDAs role in
regulating dietary supplements. 136 (2) Question: What are consumers’
comprehensions of dietary supplement label information? (2) Answer: Consumers
misunderstood the disclaimer language, with 40% believing the disclaimer meant
that insufficient research had been done to prove the claimed benefits. Consumers
also misunderstood the FDA’s role in regulating dietary supplements, with 33%
believing the disclaimer meant that the product was not approved or regulated by
the FDA. In addition, 18% believed that the DSHEA disclaimer protected the
FDA from legal action.137 (3) Question: How do consumers interpret information
on dietary supplement materials? (3) Answer: Despite nearly universal awareness
of the FD disclaimer, many participants believed that supplements’ claims were
FDA-reviewed and distrusted the FDA’s ability to effectively regulate health
products. Health risks of supplements were generally ignored. The disclaimer did
not change the FDA’s role in approving dietary supplements.138

Why “this Statement” Isn’t Evaluated by the Food and Drug and Administration,
ELYSIUM HEALTH (Oct. 2017), https://endpoints.elysiumhealth.com/fda-disclaimerexplained-5738f7aba0d5.
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When taken in context of what has already been discussed, it seems that
disclaimers in the dietary supplement world are not only irrelevant for warning
consumers, but they also seem to mislead consumers into thinking that the
manufacturer has complied with “any and all” regulations that are currently in
place for their product to be on the shelves. In support of these answers from the
surveys taken, it is explicitly clear that the disclaimer currently required is not
needed on dietary supplements. This is correct because all dietary supplements
will be going through a rigorous classification/regulating period so that all
products have in fact been tested by an organizational body. An alternate
statement on dietary supplements should be required to inform the buyer that the
product has gone through testing and regulation.
Dietary supplements should follow the recent decision by the FDA to enhance
the medical information on prescription drugs. 139 Currently, prescription
medications do not have disclaimers because they are tested rigorously by the
FDA. However, there are many requirements for those manufactures to meet if
they decide that they want to advertise their product on the television, radio, or
internet.
According to the FDA, different advertisements require different amounts of
benefit and risk information.140 For example reminder ads do not have to include
any risk information because they cannot include any claims or pictures about
what a drug does or how it works. Reminder ads are only for drugs without certain
specified serious risks. (Ibuprofen could be used in a reminder ad if the ad did not
describe or name the condition that ibuprofen treats or make dosage
recommendations.) 141 The next classification is print product claim ads – these
may make statements about a drug’s benefit(s). They must present the drug’s most
important risks in the main part of the ad (fair balance). These ads generally must
include every risk, but can present the less important risks in the detailed
information known as the brief summary.142 Print product claim ads and reminder
ads must include a disclaimer just like dietary supplements are required to.
However, the difference in the context of the disclaimer is worrying for dietary
supplement users. Print product claim and reminder ads must include the
following statement: “You are encouraged to report negative side effects of
alth_Supplement_Information_Regulations_The_Importance_of_Recognizing_Consumer
_Motivations.
139

The FDA Announces New Prescription Drug Information Format, FDA (Dec. 4,
2015),
https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/LawsActsandRu
les/ucm188665.htm (In January 2006, the FDA unveiled a major revision to the format of
prescription drug information, commonly called the package insert. To manage the risks
of medication use and to reduce medical errors, the newly designed package insert will
provide the most up-to-date information in an easy-to-read format that draws physician
and patient attention to the most important pieces of drug information before a product is
prescribed. The new format also will make prescription information more accessible for
use with electronic prescribing tools and other electronic information resources.)
140
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prescription to the FDA. Visit MedWatch or call 1-800-FDA01988.” The FDA
wants to know about side effects, they retain some sort of responsibility with their
product. They want to ensure that the public are in the safest hands possible when
it comes down to prescription medication ingestion. Whereas when compared to
the disclaimer listed on dietary supplements – the FDA is relinquishing any
responsibility by unequivocally stating that this “product has not been tested.”
New regulation would be advantageous because it would put that lost
responsibility back into the regulator and/or the organization in charge of the
testing methods. The public and the consumers would now have an easy avenue
to proceed down if they were to experience any irrational side effects. Currently,
those disclaimers placed on prescription drugs have caused the U.S. Government
to investigate illegal off-label marketing efforts by manufacturers and
subsequently they have dished out approximately $15 billion worth of civil and
criminal fines.143 The dietary supplement industry does not have the capacity to
order such fines because there is no background to support the allegations.
Manufacturers therefore look for gaps in the market, pounce upon that gap, and
subsequently take advantage of the consumer as they know that it is unlikely that
they will be reported – and if they were to be reported, the odds of a fine/penalty
in the same pedigree as prescription drugs is unimaginable. Dietary supplement
companies and manufacturers currently have a two-strike rule. It is not until the
second offense that they are to be punished.144
F.

The Marketable Product

Currently, dietary supplement manufacturers can claim anything not seriously
misleading on their product. However, there are three main categories of claims
that are defined by statute and/or FDA regulations: health claims, the nutritional
content, and structure/function claims.145
Health claims describe a relationship between a food substance (dietary
supplement ingredient), and a reduced risk or a disease or a health-related
condition. A health claim lacking these two requirements does not meet the
regulatory definition of a health claim.146 Health claims are currently regulated by
the FDA because of the potential effect that they can have on the consumer buying
the product. There are currently three ways in which the FDA exercises its
oversight in determining which health claims may or may not be used on dietary
supplements.147
(1) The 1990 Nutrition Labelling and Education Act provides for the FDA to
issue regulations authorizing health claims for foods and dietary supplements after
reviewing and evaluating the scientific evidence, either in response to a health
143
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claim petition or based on its own initiative.148 The FDA authorizes these types of
health claims based on an extensive review of the scientific literature, generally
as a result of the submission of a health claim petition, using the significant
scientific agreement standard to determine whether the substance/disease
relationship is well established.149
(2) The 1997 Food and Drug Administration Modernization Act (FDAMA)
provides for health claims based on an authoritative statement of the National
Academy of Sciences or a scientific body of the U.S. government with
responsibility for public health protection or nutrition research; such claims may
be used 120 days after a health claim notification has been submitted to FDA,
unless the agency has informed the notified that the notification does not include
all the required information.150 However, this method cannot be used for dietary
supplements at this time.151
(3) As described in FDA’s guidance entitled Interim Procedures for Qualified
Health Claims in the Labelling of conventional Human Food and Human Dietary
Supplements, the agency reviews petitions for qualified health claims where the
quality and strength of the scientific evidence falls below that required for FDA
to issue an authorizing regulation.152 This is used when there is emerging evidence
of a relationship between a food substance and reduced risk of disease or healthrelated condition, but the evidence is not well enough established to meet the
significant scientific agreement standard required for FDA to issue an authorizing
regulation. The qualified health claims petition process provides a mechanism to
request that FDA review the scientific evidence and exercise enforcement
discretion to permit the use of the qualified claim in food labelling. 153
Not only do dietary supplements contain health claims but they also contain
nutrient content claims. The nutrient content claim describes the level of a nutrient
in the product, using terms such as free, high, and low, or they compare the level
of a nutrient in a food to that of another food, using terms such as more, reduced,
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and light.154 An example of this would be when a dietary supplement states, “a
good source of Vitamin C,” or “high in antioxidants”. 155
Finally, manufacturers may include structure/function claims. These claims
describe the basic benefits of the product on a particular area or function of the
body. Examples would be, “helps support lower cholesterol,” or “helps maintain
fluid joints.” Structure/function claims must include a disclaimer to state that they
have not been evaluated by the FDA.156
Taking into account that these are the only three claims to be regulated by
statute and/or the FDA, it is far too confusing of a protocol to go through for every
product out there. It is why there are currently thousands of bottles on the shelves
of supplement stores and online that choose not to fall into one of these so that
they end up this process. However, with new regulation, all claims, no matter what
it says shall be evaluated and checked against the science. With the leeway that
manufacturers currently have, they swarm their products onto the public with
claims that are sometimes inevitably too good to be true.
From now on the labels on dietary supplements will be far easier to understand.
Packaging and labels shall be limited in the amount of information that they can
provide. Sales will be based on actual health benefits as opposed to the
marketability of a product claiming to be the “number one weight loss pill in the
U.S.” By limiting packaging to stating the name of the product, the ingredients,
the nutritional values (RDA if available), and a regulated description/statement on
what the product does; consumers will be in the driving seat as opposed to the
companies. People will be buying based on the information available that has been
supported, not on frivolous claims.
Currently, the majority of dietary supplements include the disclaimer that
there claim has not been evaluated by the FDA. This statement or “disclaimer” is
required by the DSHEA when a manufacturer makes a structure/function claim
on a dietary supplement label. The reason that a disclaimer is required is because
the manufacturer is the one who is responsible for ensuring the accuracy and
truthfulness of these claims. The law of the DSHEA states that if a dietary
supplement contains such a claim, it must in a “disclaimer” that FDA has not
evaluated this claim. The disclaimer must also state that this product is not
intended to “diagnoses, treat, cure or prevent any disease,” because only a drug
can legally make such a claim.157 As a consumer, seeing this can be daunting,
scary and confusing. Especially seeing as a portion of the public believes that
supplements are regulated like drugs. With this new reform that this paper is
proposing, there will be no need to have such a disclaimer on the product. The
manufacturers would have gone through scientific testing, similar to how drugs
are. Despite the reform not requiring that diet supplements go through the exact
same protocol as drugs; supplements will be proven safe before they go onto the
market. Thus, no such disclaimer will be required. The only statement from the

154

Id.

155

The Science Behind the Supplements, COUNCIL FOR RESPONSIBLE NUTRITION
https://www.crnusa.org/industry-regulation/regulation/product-claims.
156

157

Id.

Questions and Answers on Dietary Supplements, FDA
https://www.fda.gov/food/dietarysupplements/usingdietarysupplements/ucm480069.htm#
wording (last modified Jul. 22, 2019).

[2019]

KENNETT, TIME FOR CHANGE

77

FDA that will be on dietary supplements will be that the product has been tested
and has been proven to be safe.
A current regulation in place at the moment that is beneficial and should
remain in some shape or form is the capability of the public, or a health care
provider, to report a problem or illness caused by a dietary supplement to the
FDA. 158 Even though the protocols to file such a claim have already been
discussed in this paper, it is important to make it as easy as possible to file. When
it comes to reporting adverse events or problems, people are often worried that
what they are reporting is not linked to the dietary supplement or it was all part of
the side effects that were likely to happen. With the new reform in place, the public
should be at ease in reporting as they can now be confident that the product has
been tested and therefore any adverse events should be reported.
If a diet supplement gets reported through this new reform, then at least the
FDA can say that the product was tried and tested before it reached consumers.
They may be more aware of the potential effects, what can be changed with the
dietary supplement, and whether or not removing it from the market before the
problem is solved is the most feasible idea. Problems should be easy to report, but
this new reform shall place barriers in place to prohibit frivolous claims being
made. However, frivolous claims are often made when a dietary supplement has
not done what it said it is meant to do on the label. This is where the new reform
will prove to be beneficial because such claims cannot be made unless they have
been proven in the pre-approval stage before being allowed to be sold to the public.
The new reform will also continue to publish on a quarterly basis data that was
extracted from the agency’s adverse event reporting system. 159 These quarterly
reports will continue to include the adverse events that were submitted by
consumers, medical professionals and the industry for those three months. 160
Having such a platform available to the public will enable them to (1) check out
a diet supplement before they purchase it and (2) when they want to report a claim
then they can check if someone has reported an adverse event already that is
similar to theirs. If someone has, then this should raise a red flag when they report
it again to the FDA. If a dietary supplement ends up having a certain amount of
reports within a certain time period for the same adverse event or problem, then
that supplement shall be immediately removed from the market until the FDA has
proven that it is safe for human consumption.
The final important aspect of this reform will be current medical professionals’
ability to prescribe dietary supplements for those who are lacking vital nutrients
and minerals either in their diet or lifestyle. The reason that this will be attainable
is because doctors and physicians will now be prescribing supplements that have
been tried, tested, and proven to be safe by the FDA. There will be no liability
attached to them for prescribing a supplement that has met the required testing
protocols. Currently, doctors can prescribe certain weight loss pills but these pills

158

Id.

159

Josh Long, FDA Publishes Adverse Events on Dietary Supplements and Conventional
Foods, NATURAL PRODUCT INSIDER (Dec. 2016),
https://www.naturalproductsinsider.com/regulatory/fda-publishes-adverse-events-dietarysupplements-and-conventional-foods.
160

Id.

[Vol. 33:1]

JOURNAL OF LAW AND HEALTH

78

are classified as drugs.161 However, they usually only prescribe them only if your
BMI is 30 or higher, or if it’s at least 27 and you have a condition that may be
related to your weight, like type 2 diabetes or high blood pressure. 162 Common
prescription weight loss drugs include: Orlistat, Belviq, Contrave, Saxenda,
Phentermine, and Qsymia.163 The problem with this, is that people are often scared
about approaching a doctor because of either the cost of going to see one (people
without insurance) and/or the embarrassment about seeing one about their weight.
It is far easier for them to walk into a GNC or a Vitamin Shoppe where there is
no embarrassment attached whatsoever in picking up the fanciest looking diet pill
tub and paying very little money for something that has not been tried and tested
by the FDA.
This paper is calling for the ability to be given to doctors to prescribe diet
supplements. They will be cheaper for the consumer, they will be covered by
insurance in cases where the patient actually needs them, and the doctor will know
that what he/she is prescribing will not adversely affect their liability if such a
supplement does not work. Transparency will be higher and medical professionals
will know exactly what diet supplements have the highest success and safety rate.
VI.

CONCLUSION

The intake of diet supplements has increased astronomically within the past
decade and the future looks to be heading in the same direction. The ease in which
the public can go to a store or visit a website to buy such supplements is extremely
worrying. Given the lack of testing that gets done before they are available to
purchase, the FDA along with other agencies of the Government, need to take
action and stop with the retrospective attitude to such an important situation.
This paper shows that the current regulations in place are lacking given the
ease in which supplements are obtained by the public. If the regulation currently
in place were to remain for the next decade, then not only would there be tens of
thousands of more products on the market, but the claims which those products
would be making would continue to take advantage of the consumer. The less
educated percentage of the population are not aware of the implications that may
arise from taking such a product that claims to be the best in the market for
achieving a certain result. Through a combination of the points that this paper has
laid out, a reform will cause consumers to feel safer and more aware of the effects
when picking and choosing a supplement which they hope will aid them in their
everyday lives.
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